A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF

NCT07653100 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus (RSV)

Interventions

BIOLOGICAL: RSVpreF
BIOLOGICAL: Placebo

Sponsor

Pfizer